On NHS's 62 day(!) target (from referral to treatment) for lung cancer, there is "potential for improvement"

http://www.ncbi.nlm.nih.gov/pubmed/23162682

JRSM Short Rep. 2012 Oct;3(10):69. doi: 10.1258/shorts.2012.012058. Epub 2012 Oct 15.

Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study.

Ip H, Amer T, Dangoor M, Zamir A, Gibbings-Isaac D, Kochhar R, Heymann T.

Source

Guy's and St Thomas' NHS Foundation Trust , London SE1 7EH , UK.

Abstract

OBJECTIVES:

England's National Health Service (NHS) introduced a 62-day target, from referral to treatment, to make lung cancer patient pathways more efficient. This study aims to understand pathway delays that lead to breaches of the target when patients need care in both secondary and tertiary setting, so more than one institution is involved.

DESIGN:

Mixed methods cross case analysis.

SETTING:

Two tertiary referral hospitals in London.

PARTICIPANTS:

Database records of 53 patients were analysed. Nineteen sets of patient notes were used for pathway mapping. Seventeen doctors, four nurses, eight managers and administrators were interviewed.

MAIN OUTCOME MEASURES:

Qualitative methods include pathway mapping and semi-structured interviews. Quantitative analysis of patient pathway times from cancer services records.

RESULTS:

The majority of the patient pathway (68.4%) is spent in secondary centres. There is more variability in the processes of secondary centres but tertiary centres do not have perfect processes either. Three themes emerged from discussions: information flows, pathway performance and the role of the multidisciplinary approach.

CONCLUSIONS:

The actions of secondary centres have a greater influence on whether a patient breaches the 62-day target, compared with tertiary centres. Nevertheless variability exists in both, with potential for improvement.